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Background: Peripartum cardiomyopathy (PPCM) is rare, affecting up to 1/2000 mothers in the US. Hospital discharge data provides an 
opportunity to assemble a large number of PPCM cases.
Methods: Hospital discharge data were obtained from agencies in California, New Hampshire, New Jersey, New York, and West Virginia from 
2003-2007. Admissions including the ICD-9 CM codes 674.50-674.55 were analyzed. Data dictionaries and ICD-9 codes were used to quantify 
demographics, comorbidities, and outcomes. Analyses were conducted using MySQL Server (5.5.6).
Results: 2,067 records included a diagnosis of PPCM. Patient characteristics are shown in the Table. Hypertension, anemia, and mitral valve 
disease were common. Most patients were non-white (62.5%), > age 30 (63.3%), and post-partum (67.0%). 10.3% of patients presenting at or 
prior to delivery had multiple gestations. 44% of peri- or antepartum patients had preeclampsia or eclampsia. Length of stay at time of delivery 
was 8.8±9.2 days. Cardiac arrest was the most common serious complication (7.2%). In-hospital mortality was low at 1.8%, as was the rate of 
mechanical circulatory support (1.2%) or transplant (0.6%).
Conclusion: PPCM is a rare complication of pregnancy that preferentially affects older, non-white mothers and is associated with preeclampsia/
eclampsia, multiple gestations, hypertension, anemia, and mitral valve disease. In-hospital mortality and need for advanced heart failure therapy are low.
All White Black Hispanic Other
2067 36.5% 35.4% 21.2% 6.9%
Age
< 18 1.0% 0.2% 1.7% 1.0% 2.1%
18-29 35.7% 27.2% 38.8% 43.6% 33.0%
30-39 52.0% 59.4% 49.4% 43.6% 54.3%
40-49 10.7% 12.5% 8.9% 11.8% 10.6%
50-59 0.6% 0.8% 0.9% 0.0% 0.0%
60-69 0.1% 0.0% 0.2% 0.0% 0.0%
Payor
Medicare 4.7% 2.5% 7.1% 2.5% 6.6%
Medicaid 33.1% 28.4% 32.7% 42.3% 23.1%
Private 35.6% 37.6% 29.7% 35.5% 52.7%
Self Pay 6.9% 10.9% 6.1% 3.7% 9.9%
Other 19.7% 20.6% 24.4% 28.6% 1.9%
Comorbid conditions
Heart failure 57.1% 54.3% 59.3% 58.9% 57.0%
Preeclampsia* 39.1% 41.6% 36.5% 38.0% 48.8%
Hypertension 36.5% 30.5% 43.0% 34.1% 37.2%
Anemia 30.7% 27.9% 32.5% 32.8% 28.9%
Mitral valve disorder 14.2% 15.8% 11.3% 13.4% 17.4%
Asthma 11.0% 9.1% 14.4% 8.9% 9.1%
Multiple gestation* 10.3% 14.5% 6.8% 6.0% 17.1%
Tobacco use 10.3% 12.8% 11.0% 5.4% 5.0%
Obesity 10.1% 7.8% 12.8% 7.5% 9.1%
Diabetes 5.9% 3.3% 6.5% 7.3% 5.8%
Eclampsia* 4.9% 6.3% 5.4% 5.3% 4.9%
Outcome
Death 1.8% 0.9% 1.3% 2.2% 2.5%
Length of stay 6.8± 12.7 6.1±7.9 6.9±18.2 7.3±10.5 6.0±6.9
Shock 2.6% 1.6% 2.1% 3.2% 1.7%
Cardiac arrest 7.2% 7.4% 6.1% 7.0% 6.6%
Circulation assist device 1.2% 0.8% 1.6% 1.9% 0.0%
IABP 0.9% 0.6% 1.1% 1.3% 0.0%
Transplant 0.6% 0.8% 0.3% 0.8% 0.0%
LV assist device 0.4% 0.0% 0.8% 0.3% 0.0%
Cesarean section* 68.2% 67.5% 69.1% 67.4% 75.0%
Still born* 2.9% 1.3% 4.3% 3.5% 2.7%
*Antepartum or delivered patients only
